MacKenzie Parker

Mackenzie Parker is a Senior Scientist in Platform Discovery at Kymera Therapeutics since September 2022, bringing extensive experience in biochemistry and molecular biology. Previously, Mackenzie worked at H3 Biomedicine from March 2020 to September 2022, where roles included Investigator II and Investigator I, focusing on high-throughput screening and lead selection projects. Prior experience includes positions at New England Biolabs as a Research Scientist I and Postdoctoral Researcher, where Mackenzie applied in vivo screening methods and investigated TET dioxygenases. Mackenzie's academic background includes a Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology, where research involved the kinetics and regulation of bacterial enzymes. Early research was conducted at Montana State University-Bozeman, culminating in a Bachelor's degree in Chemistry.